-
1
-
-
0032533670
-
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
-
Devesa SS, Blot WJ, Fraumeni JF: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83:2049-2053, 1998
-
(1998)
Cancer
, vol.83
, pp. 2049-2053
-
-
Devesa, S.S.1
Blot, W.J.2
Fraumeni, J.F.3
-
2
-
-
0141506127
-
Population attributable risks of esophageal and gastric cancers
-
Engel LS, Chow WH, Vaughan TL, et al: Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 95:1404-1413, 2003
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 1404-1413
-
-
Engel, L.S.1
Chow, W.H.2
Vaughan, T.L.3
-
3
-
-
0035818048
-
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction
-
Macdonald JS, Smalley SR, Benedetti J, et al: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725-734, 2001
-
(2001)
N Engl J Med
, vol.345
, pp. 725-734
-
-
Macdonald, J.S.1
Smalley, S.R.2
Benedetti, J.3
-
4
-
-
25844528892
-
Perioperative chemotherapy in operable gastric and lower oesophageal cancer: Final results of randomized, controlled trial
-
abstr 4001
-
Cunningham D, Allum W, Stenning SP, et al: Perioperative chemotherapy in operable gastric and lower oesophageal cancer: Final results of randomized, controlled trial. J Clin Oncol 23:308, 2005 (abstr 4001)
-
(2005)
J Clin Oncol
, vol.23
, pp. 308
-
-
Cunningham, D.1
Allum, W.2
Stenning, S.P.3
-
5
-
-
27244440600
-
Phase I pharmacokinetic study of S-1 plus cisplatin in patients with advanced gastric carcinoma
-
Ajani J, Faust J, Ikeda K, et al: Phase I pharmacokinetic study of S-1 plus cisplatin in patients with advanced gastric carcinoma. J Clin Oncol 23:6957-6965, 2005
-
(2005)
J Clin Oncol
, vol.23
, pp. 6957-6965
-
-
Ajani, J.1
Faust, J.2
Ikeda, K.3
-
6
-
-
1842569206
-
A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
-
Goldberg RM, Sargent DJ, Morton RF, et al: A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22:23-30, 2004
-
(2004)
J Clin Oncol
, vol.22
, pp. 23-30
-
-
Goldberg, R.M.1
Sargent, D.J.2
Morton, R.F.3
-
7
-
-
0035871538
-
Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study. Amer Soc
-
Hoff PM, Ansari R, Batist G, et al: Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study. Amer Soc Clin Oncol 19:2282-2292, 2001
-
(2001)
Clin Oncol
, vol.19
, pp. 2282-2292
-
-
Hoff, P.M.1
Ansari, R.2
Batist, G.3
-
8
-
-
0033909505
-
Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group
-
Vanhoefer U, Rougier P, Wilke H, et al: Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. J Clin Oncol 18:2648-2657, 2000
-
(2000)
J Clin Oncol
, vol.18
, pp. 2648-2657
-
-
Vanhoefer, U.1
Rougier, P.2
Wilke, H.3
-
9
-
-
21644445993
-
Final results of randomized controlled phase III trial (TAX 325) comparing docetaxel combined with cisplatin and 5-fluorouracil to CF in patients with metastatic gastric adenocarcinoma
-
abstr 4002, 308s
-
Moiseyenko VM, Ajani J, Tjulandin SA, et al: Final results of randomized controlled phase III trial (TAX 325) comparing docetaxel combined with cisplatin and 5-fluorouracil to CF in patients with metastatic gastric adenocarcinoma. J Clin Oncol 23:308s, 2005 (abstr 4002)
-
(2005)
J Clin Oncol
, vol.23
-
-
Moiseyenko, V.M.1
Ajani, J.2
Tjulandin, S.A.3
-
10
-
-
32944474464
-
Randomized phase 3 trial of irinotecan + 5FU/folinic acid vs CDDP + 5FU in first line advanced gastric cancer patients
-
abstr 4003, 308s
-
Dank M, Zaluski J, Barone C, et al: Randomized phase 3 trial of irinotecan + 5FU/folinic acid vs CDDP + 5FU in first line advanced gastric cancer patients. J Clin Oncol 23:308s, 2005 (abstr 4003)
-
(2005)
J Clin Oncol
, vol.23
-
-
Dank, M.1
Zaluski, J.2
Barone, C.3
-
11
-
-
84871466192
-
Fluorouracil, leucovorin and oxaliplatin versus fluorouracil, leucovorin and cisplatin as first line therapy for patients with advanced gastric cancer
-
abstr 4015, 311s
-
Al-Batran SE, Stohlmacher J, Probst S, et al: Fluorouracil, leucovorin and oxaliplatin versus fluorouracil, leucovorin and cisplatin as first line therapy for patients with advanced gastric cancer. J Clin Oncol 23:311s, 2005 (abstr 4015)
-
(2005)
J Clin Oncol
, vol.23
-
-
Al-Batran, S.E.1
Stohlmacher, J.2
Probst, S.3
-
12
-
-
20044393181
-
Docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma: A randomized phase II study
-
Thuss-Patience PC, Kretzschmar A, Repp M, et al: Docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma: A randomized phase II study. J Clin Oncol 23:494-501, 2005
-
(2005)
J Clin Oncol
, vol.23
, pp. 494-501
-
-
Thuss-Patience, P.C.1
Kretzschmar, A.2
Repp, M.3
-
13
-
-
0037090686
-
Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer
-
Ross P, Nicolson M, Cunningham D, et al: Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol 20:1996-2004, 2002
-
(2002)
J Clin Oncol
, vol.20
, pp. 1996-2004
-
-
Ross, P.1
Nicolson, M.2
Cunningham, D.3
-
14
-
-
0032189218
-
Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 in advanced gastric cancer
-
Sakata Y, Ohtsu A, Horikoshi N, et al: Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 in advanced gastric cancer. Eur J Cancer 34:1715-1720, 1998
-
(1998)
Eur J Cancer
, vol.34
, pp. 1715-1720
-
-
Sakata, Y.1
Ohtsu, A.2
Horikoshi, N.3
-
15
-
-
0842330394
-
Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer
-
Koizumi W, Tanabe S, Saigenji K, et al: Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer. Br J Cancer 89:2207-2212, 2003
-
(2003)
Br J Cancer
, vol.89
, pp. 2207-2212
-
-
Koizumi, W.1
Tanabe, S.2
Saigenji, K.3
-
16
-
-
0242330299
-
Comparison of pharmacokinetics of S-1, an oral anticancer agent, in Western and Japanese patients
-
Comets E, Ikeda K, Hoff P, et al: Comparison of pharmacokinetics of S-1, an oral anticancer agent, in Western and Japanese patients. J Pharmacokinet Pharmacodyn 30:257-283, 2003
-
(2003)
J Pharmacokinet Pharmacodyn
, vol.30
, pp. 257-283
-
-
Comets, E.1
Ikeda, K.2
Hoff, P.3
|